Dendritic cell-specific transcript: Dendritic cell marker and regulator of TLR-induced cytokine production

Journal of Immunology

Volumn 189, Issue 1, 2012, Pages 138-145

  Hontelez, Saartje ^a   Ansems, Marleen ^a   Karthaus, Nina ^a   Zuidscherwoude, Malou ^a   Looman, Maaike W ^a   Triantis, Vassilis ^b   Adema, Gosse J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DENDRITIC CELL SPECIFIC TRANSCRIPT PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; MESSENGER RNA; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS REGULATION; WILD TYPE;

BIOLOGICAL MARKERS; CARRIER PROTEINS; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-10; INTERLEUKIN-4; MOLECULAR DYNAMICS SIMULATION; MONOCYTES; RNA, MESSENGER; TOLL-LIKE RECEPTORS;

EID: 84862858991     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103709     Document Type: Article

References (47)

1. Ueno, H., E. Klechevsky, R. Morita, C. Aspord, T. Cao, T. Matsui, T. Di Pucchio, J. Connolly, J.W. Fay, V. Pascual, et al. 2007. Dendritic cell subsets in health and disease. Immunol. Rev. 219: 118-142. (Pubitemid 47393528)
2. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252. (Pubitemid 28155090)
3. Schwartz, R. H. 2003. T cell anergy. Annu. Rev. Immunol. 21: 305-334. (Pubitemid 37174534)
4. Cools, N., P. Ponsaerts, V. F. Van Tendeloo, and Z. N. Berneman. 2007. Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells. J. Leukoc. Biol. 82: 1365-1374. (Pubitemid 350276946)
5. Jonuleit, H., E. Schmitt, K. Steinbrink, and A. H. Enk. 2001. Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol. 22: 394-400. (Pubitemid 32673646)
6. Geissmann, F., M. G. Manz, S. Jung, M. H. Sieweke, M. Merad, and K. Ley. 2010. Development of monocytes, macrophages, and dendritic cells. Science 327: 656-661.
7. Ueno, H., A. K. Palucka, and J. Banchereau. 2010. The expanding family of dendritic cell subsets. Nat. Biotechnol. 28: 813-815.
8. Merad, M., and M. G. Manz. 2009. Dendritic cell homeostasis. Blood 113: 3418-3427.
9. Thurner, B., C. Röder, D. Dieckmann, M. Heuer, M. Kruse, A. Glaser, P. Keikavoussi, E. Kämpgen, A. Bender, and G. Schuler. 1999. Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. J. Immunol. Methods 223: 1-15. (Pubitemid 29096234)
10. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179: 1109-1118.
11. Romani, N., S. Gruner, D. Brang, E. Kämpgen, A. Lenz, B. Trockenbacher, G. Konwalinka, P. O. Fritsch, R. M. Steinman, and G. Schuler. 1994. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180: 83-93. (Pubitemid 24181058)
12. Hiasa, M., M. Abe, A. Nakano, A. Oda, H. Amou, S. Kido, K. Takeuchi, K. Kagawa, K. Yata, T. Hashimoto, et al. 2009. GM-CSF and IL-4 induce dendritic cell differentiation and disrupt osteoclastogenesis through M-CSF receptor shedding by up-regulation of TNF-alpha converting enzyme (TACE). Blood 114: 4517-4526.
13. Carreras, E., S. Turner, M. B. Frank, N. Knowlton, J. Osban, M. Centola, C. G. Park, A. Simmons, J. Alberola-Ila, and S. Kovats. 2010. Estrogen receptor signaling promotes dendritic cell differentiation by increasing expression of the transcription factor IRF4. Blood 115: 238-246.
14. Tamura, T., P. Tailor, K. Yamaoka, H. J. Kong, H. Tsujimura, J. J. O'Shea, H. Singh, and K. Ozato. 2005. IFN regulatory factor-4 and -8 govern dendritic cell subset development and their functional diversity. J. Immunol. 174: 2573-2581. (Pubitemid 40279670)
15. Suzuki, S., K. Honma, T. Matsuyama, K. Suzuki, K. Toriyama, I. Akitoyo, K. Yamamoto, T. Suematsu, M. Nakamura, K. Yui, and A. Kumatori. 2004. Critical roles of interferon regulatory factor 4 in CD11bhighCD8alpha- dendritic cell development. Proc. Natl. Acad. Sci. USA 101: 8981-8986. (Pubitemid 38781597)
16. Dakic, A., L. Wu, and S. L. Nutt. 2007. Is PU.1 a dosage-sensitive regulator of haemopoietic lineage commitment and leukaemogenesis? Trends Immunol. 28: 108-114. (Pubitemid 46283693)
17. Carotta, S., A. Dakic, A. D'Amico, S. H. Pang, K. T. Greig, S. L. Nutt, and L. Wu. 2010. The transcription factor PU.1 controls dendritic cell development and Flt3 cytokine receptor expression in a dose-dependent manner. Immunity 32: 628-641.
18. Shivdasani, R. A., and S. H. Orkin. 1996. The transcriptional control of hematopoiesis. Blood 87: 4025-4039. (Pubitemid 26152245)
19. Triantis, V., D. E. Trancikova, M. W. Looman, F. C. Hartgers, R. A. Janssen, and G. J. Adema. 2006. Identification and characterization of DC-SCRIPT, a novel dendritic cell-expressed member of the zinc finger family of transcriptional regulators. J. Immunol. 176: 1081-1089. (Pubitemid 43099709)
20. Ansems, M., S. Hontelez, M. W. Looman, N. Karthaus, P. Bult, J. J. Bonenkamp, J. H. Jansen, F. C. Sweep, P. N. Span, and G. J. Adema. 2010. DC-SCRIPT: nuclear receptor modulation and prognostic significance in primary breast cancer. J. Natl. Cancer Inst. 102: 54-68.
21. Sieuwerts, A. M., M. Ansems, M. P. Look, P. N. Span, V. de Weerd, A. van Galen, J. A. Foekens, G. J. Adema, and J. W. Martens. 2010. Clinical significance of the nuclear receptor co-regulator DC-SCRIPT in breast cancer: an independent retrospective validation study. Breast Cancer Res. 12: R103.
22. Gilligan, P., S. Brenner, and B. Venkatesh. 2002. Fugu and human sequence comparison identifies novel human genes and conserved non-coding sequences. Gene 294: 35-44. (Pubitemid 35291011)
23. Triantis, V., V. Moulin, M. W. Looman, F. C. Hartgers, R. A. Janssen, and G. J. Adema. 2006. Molecular characterization of the murine homologue of the DC-derived protein DC-SCRIPT. J. Leukoc. Biol. 79: 1083-1091. (Pubitemid 44835595)
24. Lopez-Garcia, J., M. Periyasamy, R. S. Thomas, M. Christian, M. Leao, P. Jat, K. B. Kindle, D. M. Heery, M. G. Parker, L. Buluwela, et al. 2006. ZNF366 is an estrogen receptor corepressor that acts through CtBP and histone deacetylases. Nucleic Acids Res. 34: 6126-6136. (Pubitemid 44942734)
25. Ottow, E., and H. Weinmann. 2008. Nuclear Receptors as Drug Targets. Wiley-VCH, Weinheim, Germany.
26. Gronemeyer, H., J. A. Gustafsson, and V. Laudet. 2004. Principles for modulation of the nuclear receptor superfamily. Nat. Rev. Drug Discov. 3: 950-964. (Pubitemid 39534319)
27. Chow, E. K., B. Razani, and G. Cheng. 2007. Innate immune system regulation of nuclear hormone receptors in metabolic diseases. J. Leukoc. Biol. 82: 187-195. (Pubitemid 47230626)
28. Lonard, D. M., R. B. Lanz, and B. W. O'Malley. 2007. Nuclear receptor coregulators and human disease. Endocr. Rev. 28: 575-587. (Pubitemid 47236337)
29. O'Malley, B. 2008. The Year in Basic Science: nuclear receptors and coregulators. Mol. Endocrinol. 22: 2751-2758.
30. O'Malley, B. W., and R. Kumar. 2009. Nuclear receptor coregulators in cancer biology. Cancer Res. 69: 8217-8222.
31. de Vries, I. J., A. A. Eggert, N. M. Scharenborg, J. L. Vissers, W. J. Lesterhuis, O. C. Boerman, C. J. Punt, G. J. Adema, and C. G. Figdor. 2002. Phenotypical and functional characterization of clinical grade dendritic cells. J. Immunother. 25: 429-438.
32. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408. (Pubitemid 34164012)
33. Schuurhuis, D. H., W. J. Lesterhuis, M. Kramer, M. G. Looman, M. van Hout-Kuijer, G. Schreibelt, A. C. Boullart, E. H. Aarntzen, D. Benitez-Ribas, C. G. Figdor, et al. 2009. Polyinosinic polycytidylic acid prevents efficient antigen expression after mRNA electroporation of clinical grade dendritic cells. Cancer Immunol. Immunother. 58: 1109-1115.
34. te Velde, A. A., J. P. Klomp, B. A. Yard, J. E. de Vries, and C. G. Figdor. 1988. Modulation of phenotypic and functional properties of human peripheral blood monocytes by IL-4. J. Immunol. 140: 1548-1554.
35. Roy, K. C., G. Bandyopadhyay, S. Rakshit, M. Ray, and S. Bandyopadhyay. 2004. IL-4 alone without the involvement of GM-CSF transforms human peripheral blood monocytes to a CD1a(dim), CD83(+) myeloid dendritic cell subset. J. Cell Sci. 117: 3435-3445. (Pubitemid 39206384)
36. Geijtenbeek, T. B., R. Torensma, S. J. van Vliet, G. C. van Duijnhoven, G. J. Adema, Y. van Kooyk, and C. G. Figdor. 2000. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100: 575-585.
37. Germain, P., B. Staels, C. Dacquet, M. Spedding, and V. Laudet. 2006. Overview of nomenclature of nuclear receptors. Pharmacol. Rev. 58: 685-704. (Pubitemid 44833739)
38. Glass, C. K., and M. G. Rosenfeld. 2000. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14: 121-141. (Pubitemid 30070977)
39. Mangelsdorf, D. J., C. Thummel, M. Beato, P. Herrlich, G. Schütz, K. Umesono, B. Blumberg, P. Kastner, M. Mark, P. Chambon, and R. M. Evans. 1995. The nuclear receptor superfamily: the second decade. Cell 83: 835-839.
40. Ribeiro, R. C., P. J. Kushner, and J. D. Baxter. 1995. The nuclear hormone receptor gene superfamily. Annu. Rev. Med. 46: 443-453.
41. Lazar, M. A. 2003. Nuclear receptor corepressors. Nucl. Recept. Signal. 1: e001.
42. Takeda, K., and S. Akira. 2004. TLR signaling pathways. Semin. Immunol. 16: 3-9. (Pubitemid 38147427)
43. Saraiva, M., and A. O'Garra. 2010. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 10: 170-181.
44. Gringhuis, S. I., J. den Dunnen, M. Litjens, B. van Het Hof, Y. van Kooyk, and T. B. Geijtenbeek. 2007. C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB. Immunity 26: 605-616. (Pubitemid 46756345)
45. Steinman, R. M., D. Hawiger, and M. C. Nussenzweig. 2003. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21: 685-711. (Pubitemid 37174545)
46. Platzer, C., C. Meisel, K. Vogt, M. Platzer, and H. D. Volk. 1995. Up-regulation of monocytic IL-10 by tumor necrosis factor-alpha and cAMP elevating drugs. Int. Immunol. 7: 517-523.
47. Ma, W., W. Lim, K. Gee, S. Aucoin, D. Nandan, M. Kozlowski, F. Diaz-Mitoma, and A. Kumar. 2001. The p38 mitogen-activated kinase pathway regulates the human interleukin-10 promoter via the activation of Sp1 transcription factor in lipopolysaccharide-stimulated human macrophages. J. Biol. Chem. 276: 13664-13674.